Stay updated on APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial
Sign up to get notified when there's something new on the APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial page.

Latest updates to the APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial page
- Check3 days agoChange DetectedFooter revision updated from v3.3.3 to v3.3.4. This is a minor version update and does not affect the study information or how users interact with the page.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded a consolidated Locations section listing study sites by state (California, Florida, Iowa, Minnesota, North Carolina, Tennessee, Washington) and removed the prior per-state location headings.SummaryDifference0.8%

- Check53 days agoChange DetectedThe Publications description in the Study Details section was updated to specify that publications are automatically filled from PubMed, with a revision label showing v3.3.2; the previous text described PubMed-derived publications and listed an older revision (v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check61 days agoChange DetectedRemoved the site-wide notice about government funding and operating status. This change does not affect the study details or participation information.SummaryDifference0.4%

- Check75 days agoChange DetectedNo additions or deletions detected in the Study Details page for NCT03226678; core study information remains unchanged.SummaryDifference0.4%

- Check104 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference3%

Stay in the know with updates to APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial page.